Investment Summary

Signet Healthcare Partners Invests In RK Pharma

On August 5, 2019, growth capital firm Signet Healthcare Partners invested in life science company RK Pharma

Investment Highlights
  • This is Signet Healthcare Partners’ 7th transaction in the Life Science sector.
  • This is Signet Healthcare Partners’ 6th transaction in the United States.
  • This is Signet Healthcare Partners’ 1st transaction in New York.

Investment Summary
Date 2019-08-05
Target RK Pharma
Sector Life Science
Investor(s) Signet Healthcare Partners
Deal Type Growth Capital
Advisor(s) Sheppard Mullin (Legal)

Target

RK Pharma

Pearl River, New York, United States
RK Pharma is a fully integrated generic pharmaceutical company that develops complex API and injectable finished dosage products. RK Pharma was founded in 2018 and is based in Pearl River, New York.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Signet Healthcare Partners

Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1998
PE ASSETS 600M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.

DEAL STATS #
Overall 9 of 15
Sector (Life Science) 7 of 12
Type (Growth Capital) 5 of 10
State (New York) 1 of 1
Country (United States) 6 of 8
Year (2019) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-22 Goodwin Biotechnology

Plantation, Florida, United States

Goodwin Biotechnology is a uniquely qualified and flexible, US-based CDMO that offers a Single Source Solution™ for their clients from cell line development, exploratory proof-of-concept projects through process development and cGMP contract manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and Biologic Drug Conjugates including Antibody Drug Conjugates (ADCs) for early- and late-stage clinical trials. Goodwin Biotechnology is based in Plantation, Florida.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-22 Altasciences

Laval, Quebec, Canada

Altasciences is a forward-thinking, mid-sized contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. Altasciences was founded in 1992 and is based in Laval, Quebec.

Buy -
Mergr

Product

Company

Legal